![]() |
市场调查报告书
商品编码
1503377
至 2030 年血管内超音波设备市场预测 - 按产品、模式、应用、最终用户和地理位置进行的全球分析Intravascular Ultrasound Devices Market Forecasts to 2030 - Global Analysis By Product, Modality, Application, End User and By Geography |
根据 Stratistics MRC 的数据,2024 年全球血管内超音波 (IVUS) 设备市场规模为 25.9 亿美元,预计到 2030 年将达到 45.2 亿美元,预测期内复合年增长率为 7.1%。血管内超音波 (IVUS) 设备是在心导管插入术过程中使用的医疗仪器,可提供血管内部的详细影像。这些设备利用连接到插入血管的导管上的微型探针发出的高频声波。 IVUS 可以即时显示血管壁、检测斑块积聚、评估血管尺寸并帮助制定治疗计划。 IVUS 帮助心臟科医师就支架置入术、斑块旋切术或其他干预措施做出明智的决定,以改善患者的治疗效果。
根据美国疾病管制与预防中心 (CDC) 的数据,每年约有 805,000 名美国人患有心臟病;其中 605,000 例心臟病是首次发作,20 万例发生在已经经历过心臟病的人中,五分之一的心臟病发作是无症状的。
心血管疾病发生率不断上升
IVUS 设备透过提供血管内部的详细影像,在诊断和管理心血管疾病方面发挥着至关重要的作用。 IVUS 技术能够精确评估斑块形成和动脉尺寸,有助于做出准确的治疗决策并改善患者的治疗效果。随着医疗保健提供者越来越重视心血管疾病的早期检测和干预,在技术进步和医疗保健专业人员意识不断提高的推动下,IVUS 设备市场持续扩大。
报销政策不一致
由于不同地区或医疗保健系统的法规和标准不同,血管内超音波 (IVUS) 设备的报销政策不一致。这些不一致给医疗保健提供者带来了报销资格和费率方面的不确定性,可能会阻碍对 IVUS 技术的投资。如果没有明确的经济诱因,供应商可能会犹豫是否采用 IVUS 设备,从而限制了市场扩张。
扩大医疗基础设施
扩大医疗基础设施可促进先进医疗技术的普及,从而支持血管内超音波 (IVUS) 设备市场的成长。改善的医疗设施使更多的医院和诊所能够采用 IVUS 设备,从而提高诊断能力和患者治疗效果。此外,基础设施扩张包括增加医疗保健专业人员的培训机会,从而提高 IVUS 技术的采用率。
昂贵的 IVUS 设备和程序
IVUS 设备和程序的高成本阻碍了市场成长,这主要是由于医疗保健提供者和患者面临的财务限制。购买 IVUS 设备所需的初始投资庞大,限制了其采用,特别是在资源有限的地区。此外,IVUS 手术的费用可能会让患者望而却步,从而减少了需求。这些因素限制了先进诊断能力和创新治疗方案的取得,从而阻碍了市场扩张。
Covid-19 影响
由于医疗资源被转移来应对危机,covid-19 大流行对血管内超音波 (IVUS) 设备市场产生了重大影响。选择性手术(包括使用 IVUS 的手术)被推迟或取消,导致设备利用率和销售下降。然而,随着医疗保健系统适应并恢復择期手术,IVUS 需求开始復苏,这得益于其在心血管诊断和治疗计划中的重要作用。随着医疗服务逐渐恢復正常,市场可望发展稳定。
IVUS 导管领域预计将在预测期内成为最大的领域
IVUS 导管领域预计将出现利润丰厚的成长。 IVUS 导管是用于可视化和评估血管内部的医疗设备。它们利用高频声波产生血管壁的详细影像,为临床医生提供有关动脉粥状硬化程度、斑块形态和血管尺寸的重要见解。 IVUS 导管在指导血管成形术和支架置入等介入手术中发挥关键作用,透过直接从动脉内精确评估血管病理学来帮助优化治疗结果。
预计週边血管成像领域在预测期内的复合年增长率最高
预计週边血管成像领域在预测期内将出现最快的复合年增长率。 IVUS 设备在周边血管成像中发挥重要作用,有助于血管内部的高解析度可视化。这些设备利用声波产生详细的横断面影像,有助于评估血管形态、斑块成分和狭窄严重程度。 IVUS 设备可即时了解血管结构和病理学。
在亚太地区,心血管疾病盛行率增加、医疗基础设施改善和医疗支出增加推动血管内超音波 (IVUS) 设备市场不断增长。中国、日本和印度等国家因其庞大的患者群体和不断扩大的医疗服务而成为这一增长的主要贡献者。此外,技术进步和微创手术的广泛采用正在提高 IVUS 设备的利用率。
在北美,血管内超音波 (IVUS) 设备市场十分成熟,其特点是先进的医疗基础设施、创新医疗技术的高采用率以及研发方面的大量投资。美国由于其庞大的患者群体、强劲的医疗保健支出以及主要市场参与者的强大影响力而在市场份额方面处于领先地位。 IVUS设备广泛用于心血管疾病的诊断和治疗,推动市场成长。
2024 年 5 月,Provisio Medical, Inc. 宣布利用 Provisio SLT 血管内超音波 (IVUS) 系统完成了首个商业临床案例。有慢性和肢体威胁性缺血的患者的适当治疗至关重要。
2023 年 10 月,Evident Vascular 推出了经导管 IVUS,并获得了 Vensana Capital 的 3,500 万美元 A 轮融资,用于开发血管内超音波 (IVUS) 平台。它旨在捕捉血管内部的图像,以评估血管疾病并指导介入治疗。
According to Stratistics MRC, the Global Intravascular Ultrasound (IVUS) Devices Market is accounted for $2.59 billion in 2024 and is expected to reach $4.52 billion by 2030 growing at a CAGR of 7.1% during the forecast period. Intravascular ultrasound (IVUS) devices are medical instruments used during cardiac catheterization procedures to provide detailed images of blood vessel interiors. These devices utilize high-frequency sound waves emitted from a tiny probe attached to a catheter, which is inserted into the blood vessel. IVUS enables real-time visualization of the vessel walls, detecting plaque buildup, assessing vessel dimensions, and aiding in treatment planning. IVUS helps cardiologists make informed decisions regarding stenting, atherectomy, or other interventions to improve patient outcomes.
According to the Centers for Disease Control and Prevention (CDC), each year, about 805,000 Americans experience a heart attack; 605,000 of those heart attacks are the first ones and 200,000 occur in individuals who have already experienced one, and 1 in 5 heart attacks are silent.
Growing incidenceof cardiovascular diseases
IVUS devices play a crucial role in diagnosing and managing cardiovascular conditions by providing detailed imaging of blood vessels from within. IVUS technology enables precise assessment of plaque buildup and artery dimensions, aiding in accurate treatment decisions and improving patient outcomes. As healthcare providers increasingly prioritize early detection and intervention for cardiovascular diseases, the IVUS devices market continues to expand, driven by advancements in technology and rising awareness among healthcare professionals.
Inconsistent reimbursement policies
Inconsistent reimbursement policies in intravascular ultrasound (IVUS) devices arise due to varying regulations and criteria across different regions or healthcare systems. These inconsistencies create uncertainty for healthcare providers regarding reimbursement eligibility and rates, potentially deterring investment in IVUS technology. Providers may hesitate to adopt IVUS devices without clear financial incentives, limiting market expansion.
Expanding healthcare infrastructure
Expanding healthcare infrastructure supports the growth of the intravascular ultrasound (IVUS) devices market by facilitating greater accessibility to advanced medical technologies. Improved healthcare facilities enable more hospitals and clinics to adopt IVUS devices, enhancing diagnostic capabilities and patient outcomes. Additionally, infrastructure expansion includes increased training opportunities for healthcare professionals, boosting the adoption rate of IVUS technology.
Expensive IVUS equipment and procedures
The high cost of IVUS equipment and procedures hampers market growth primarily due to financial constraints faced by healthcare providers and patients. The initial investment required for purchasing IVUS equipment is substantial, limiting adoption, especially in resource-constrained regions. Moreover, the cost of IVUS procedures can be prohibitive for patients, reducing demand. These factors hinder market expansion by restricting access to advanced diagnostic capabilities and innovative treatment options.
Covid-19 Impact
The covid-19 pandemic significantly impacted the intravascular ultrasound (IVUS) devices market as healthcare resources were diverted to manage the crisis. Elective procedures, including those using IVUS, were postponed or cancelled, leading to a decline in device utilization and sales. However, as healthcare systems adapted and resumed elective surgeries, IVUS demand began recovering, driven by its essential role in cardiovascular diagnostics and treatment planning. The market is expected to stabilize as healthcare services gradually return to normalcy.
The IVUS catheters segment is expected to be the largest during the forecast period
The IVUS catheters segment is estimated to have a lucrative growth. IVUS catheters are medical devices used to visualize and assess the interior of blood vessels. They employ high-frequency sound waves to generate detailed images of vessel walls, providing clinicians with crucial insights into the extent of atherosclerosis, plaque morphology, and vessel dimensions. IVUS catheters play a pivotal role in guiding interventional procedures like angioplasty and stent placement, helping to optimize treatment outcomes by enabling precise assessment of vessel pathology directly from within the artery.
The peripheral vascular imaging segment is expected to have the highest CAGR during the forecast period
The peripheral vascular imaging segment is anticipated to witness the fastest CAGR growth during the forecast period. IVUS devices are instrumental in peripheral vascular imaging, facilitating high-resolution visualization of blood vessel interiors. These devices utilize sound waves to produce detailed cross-sectional images, aiding in the assessment of vessel morphology, plaque composition, and stenosis severity. IVUS devices offer real-time insights into vessel structure and pathology.
In the Asia-Pacific region, the Intravascular Ultrasound (IVUS) Devices market is experiencing growth driven by increasing cardiovascular disease prevalence, improving healthcare infrastructure, and rising healthcare expenditure. Countries like China, Japan, and India are key contributors to this growth due to their large patient populations and expanding healthcare access. Additionally, technological advancements and greater adoption of minimally invasive procedures are boosting IVUS device utilization.
In North America, the Intravascular Ultrasound (IVUS) Devices market is well-established and characterized by advanced healthcare infrastructure, high adoption rates of innovative medical technologies, and significant investments in research and development. The United States leads in market share due to its large patient population, robust healthcare spending, and strong presence of key market players. IVUS devices are widely used in the diagnosis and treatment of cardiovascular diseases, driving market growth.
Key players in the market
Some of the key players profiled in the Intravascular Ultrasound (IVUS) Devices Market include Boston Scientific Corporation, Philips Healthcare, Abbott Laboratories, Terumo Corporation, Siemens Healthineers, Medtronic plc, GE Healthcare, Provisio Medical Inc., Avinger Inc., Infraredx Inc., Evident Vascular, Nipro Corporation, Koninklijke Philips N.V., Samsung Medison, Esaote SpA, Volcano Corporation
In May 2024, Provisio Medical, Inc., announced the completion of the first commercial clinical cases utilizing the Provisio SLT intravascular ultrasound (IVUS) system.It gives rapid, novel, and extremely precise way to get the size and contour of vessels, which is critical for the appropriate treatment of a patient with chronic and limb threatening ischemia.
In October2023, Evident Vascular has launched IVUS transcatheterwith $35m in Series A financing from Vensana Capital for the development of an intravascular ultrasound (IVUS) platform. It is designed to capture images from inside blood vessels to assess vascular disease and guide interventional treatment.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.